Abstract:
PROBLEM TO BE SOLVED: To provide a method for producing an organic compound, by which the organic compound having a nitrogen atom-containing group, such as an oxime, can simply be produced from inexpensive raw materials under mild conditions. SOLUTION: This method for producing the organic compound is characterized by reacting (A) a radical-producible compound with (B) a nitrite ester or nitrite salt in the presence of a nitrogen atom-containing cyclic compound containing a skeleton represented by formula (i) [X is oxygen or OR (R is H or a hydroxy group-protecting group)] as a constituent of the ring. The nitrogen atom-containing cyclic compound includes a cyclic imide-based compound having a cyclic imide skeleton represented by formula (I) [(n) is 0 or 1; X is O or OR (R is H or a hydroxy group-protecting group)]. COPYRIGHT: (C)2004,JPO
Abstract:
The present invention includes novel substituted bicyclic (such as 4-substituted-chromane-8-carboxamide compounds), and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and compositions of the invention are capsid inhibitors.
Abstract:
The invention discloses organometallic molybdenum acetylide dioxo complex of formula (η 5 -C 5 H 5 )MoO 2 (-Cs≡CPh) and provides a simple, short, efficient process for the synthesis of organometallic molybdenum dioxo complex which is used as catalyst for a number of oxidation reactions.
Abstract:
Carbon monoxide-releasing organic molecules are described herein. The molecules can be synthesized prior to administration ( e.g., ex vivo ) or formed in vivo . In those embodiments where the molecules are formed in vivo , reactants are administered under physiological conditions and undergo a cycloaddition reaction to form a product which releases carbon monoxide. In applying such reactions for therapeutic applications in vivo , the cycloaddition and CO release typically occur only under near-physiological or physiological conditions. For example, in some embodiments, the cycloaddition reaction and/or release of carbon monoxide occur at a temperature of about 37° C and pH of about 7.4. Pharmaceutical compositions and methods for release carbon monoxide are also described.
Abstract:
Provided is a solid-supported ruthenium complex represented by general formula (1), (2) or (3). Further provided are: a method for manufacturing a reduction product by reducing an organic compound in the presence of the solid-supported ruthenium complex and a hydrogen donor; a method for manufacturing an optically active alcohol, characterized by reducing a carbonyl group in a carbonyl compound in the presence of the solid-supported ruthenium complex and a hydrogen donor; and a method for manufacturing an optically active amine, characterized by reducing an imino group of an imine compound in the presence of the solid-supported ruthenium complex and a hydrogen donor.
Abstract:
The invention concerns a method of nitrosation of a phenolic compound substituted by an electro-attracting group.The invention also concerns a method of nitration of a phenoic compound substituted by an electro-attracting group. The nitrosation method is characterised in that it consists in effecting the nitrosatio n of the said compound in presence of sulphuric acid; the concentration of the sulphuric acid being at least 60 % by weight, then optionally in effecting the separation of the resulting nitrosated compound. The invention also concerns the oxidation of the resulting p-nitrosated phenolic compound for obtaining the corresponding nitrated compound.